Latest News About Pcos Renamed

PCOS (“polycystic ovary syndrome”) has reportedly been officially renamed to Polyendocrine Metabolic Ovarian Syndrome (PMOS), following a global consensus highlighted by major medical organizations in mid-May 2026.[1][2]

What the new name is meant to reflect

The change is intended to better communicate that the condition is multisystem (involving hormonal/endocrine and metabolic aspects, not just ovarian cysts or a purely gynecologic framing).[2][1]

Implementation timing (as reported)

Some reporting indicates the shift would be introduced gradually, with broader guideline integration expected later (e.g., referenced timelines point toward full incorporation by 2028).[3]

Where to read more

• CU Anschutz coverage of the name change (includes context on the consensus and rationale).[1]
• The Endocrine Society (press/advocacy update on “PMOS” as the new name).[2]

If you tell me what country you care about (UK vs US vs elsewhere) I can summarize what the change means for patients/clinicians there (e.g., NHS vs local guideline adoption)—the rollout details can vary by system.